peter attia on semaglutide 246 - AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent peter attia on semaglutide may

At Noom, our mission is to empower everyone, everywhere to live a better, healthier life

Along with novel immunology agents, we expect GLP-1 drugs to realign the pharmaceutical market

Clinical trials have shown positive results regarding the efficacy of AOD-9604 for weight loss in humans, with one study reporting an average loss of 2.6 kg over 12 weeks, compared to 0.8 kg in the placebo group

The decision to prescribe Wegovy to someone with epilepsy requires careful consideration of several factors, including the type and severity of epilepsy, current seizure control, the specific anti-epileptic medications being taken, and overall health status

Always verify your specific plan's formulary

Consider the degree of weight loss needed